Maintaining your credentials as a Physician Assistant (PA) requires a strategic approach to Continuing Medical Education (CME). While the NCCPA requires 100 hours of total CME every two years, specific state licensing boards and prescriptive authority mandates often necessitate a dedicated portion of those hours to be in pharmacology. For many PAs, the challenge lies in balancing a full clinical load with the need for high-quality, relevant pharmacology training that doesn't lead to professional burnout.
The Pharmacology CME Review Package is designed by PAs to solve this problem through efficiency and high-yield content delivery.
One of the most effective ways to avoid burnout while meeting your 100-hour requirement is to utilize AAPA Category 1 Self-Assessment CME. The NCCPA applies a 1.5x multiplier to these credits. This means that completing our 12-hour pharmacology course actually counts as 18 credits toward your 100-hour NCCPA total. This allows you to spend less time in front of a screen and more time focusing on your clinical practice or personal life.
When seeking online pharmacology CME for PAs, you must ensure the content is accredited and recognized by the NCCPA. Our course is explicitly reviewed and approved for 12 AAPA Category 1 pharmacology credits, satisfying both national requirements and state-specific prescriptive authority mandates in jurisdictions like Maryland or Ohio.
Your patient is a 64-year-old male with a history of hypertension (HTN) and stable angina. He presents for a routine follow-up. His blood pressure today is 152/94 mmHg, and his heart rate (HR) is 78 bpm. He is currently taking Lisinopril 20mg daily and HCTZ 25mg daily. You decide to add a calcium channel blocker to his regimen. Which of the following is the most appropriate next step given his history of stable angina?
A) Nifedipine (Procardia)
B) Amlodipine (Norvasc)
C) Verapamil (Calan)
D) Diltiazem (Cardizem)
Explanation: The correct answer is B) Amlodipine (Norvasc). Amlodipine is a dihydropyridine calcium channel blocker that is effective for both hypertension and stable angina without causing significant negative inotropy compared to non-dihydropyridines. While Verapamil and Diltiazem are calcium channel blockers, they are non-dihydropyridines that can significantly lower heart rate and decrease myocardial contractility, which may be less desirable if the patient were to develop heart failure or bradycardia. Nifedipine, particularly short-acting formulations, can cause reflex tachycardia, which can worsen myocardial oxygen demand in patients with angina.
While the NCCPA provides a national standard, PAs must remain vigilant regarding state-level variations. Some states require as few as 8 hours of pharmacology, while others demand more extensive training linked to your DEA license and prescriptive privileges. Using a dedicated online pharmacology CME for PAs ensures that you are not just checking a box, but reinforcing clinical knowledge that directly impacts patient safety and therapeutic outcomes.
Efficiency in learning is achieved by focusing on high-yield topics: pharmacokinetics, pharmacodynamics, and the most commonly prescribed drug classes in primary care and internal medicine. This includes the latest updates in SGLT2 inhibitors, GLP-1 agonists, and advanced anticoagulation management.
Your patient is a 52-year-old female with Type 2 Diabetes Mellitus (T2DM) and a BMI of 34. Her current A1c is 8.2% despite maximal doses of Metformin. She has a history of mild heart failure with preserved ejection fraction (HFpEF). Which of the following medication classes provides the dual benefit of improving glycemic control and reducing the risk of heart failure hospitalization?
A) Sulfonylureas (e.g., Glipizide)
B) DPP-4 Inhibitors (e.g., Sitagliptin)
C) SGLT2 Inhibitors (e.g., Empagliflozin)
D) Thiazolidinediones (e.g., Pioglitazone)
Explanation: The correct answer is C) SGLT2 Inhibitors (e.g., Empagliflozin). SGLT2 inhibitors have been shown in major clinical trials to significantly reduce the risk of hospitalization for heart failure and provide cardiovascular protection, making them a first-line choice for patients with T2DM and HF. Sulfonylureas are effective for lowering glucose but are associated with weight gain and hypoglycemia. DPP-4 inhibitors are generally weight-neutral but do not offer the same cardiovascular benefits. Thiazolidinediones are contraindicated in symptomatic heart failure due to the risk of fluid retention and exacerbation of HF symptoms.
Many PAs are provided with a fixed annual CME allowance. A common mistake is letting these funds expire or spending them on expensive travel that doesn't provide high-yield credits. We offer a pragmatic solution: CME with Amazon and Apple Gift Card add-ons.
By selecting a gift card add-on between $100 and $1,500, you can use your employer-provided education budget to acquire the necessary AAPA Category 1 pharmacology credit while also receiving a gift card to further enrich your education through books, medical equipment, or technology. This approach maximizes the value of every dollar spent and simplifies the procurement process for professional development materials.
Your patient is a 28-year-old female presenting with symptoms of an uncomplicated urinary tract infection (UTI). She has a known history of a "severe rash" when taking Sulfamethoxazole/Trimethoprim (Bactrim) in childhood. Which of the following is the most appropriate first-line treatment for her UTI, assuming local resistance patterns are low?
A) Nitrofurantoin (Macrobid)
B) Ciprofloxacin (Cipro)
C) Amoxicillin
D) Cephalexin (Keflex)
Explanation: The correct answer is A) Nitrofurantoin (Macrobid). Nitrofurantoin is a first-line agent for uncomplicated cystitis and is safe to use in a patient with a sulfa allergy. While Fluoroquinolones like Ciprofloxacin are effective, they are generally reserved for more complicated infections or when first-line agents cannot be used, due to the risk of significant side effects (e.g., tendon rupture, QTc prolongation). Amoxicillin and Cephalexin are generally less effective for UTIs compared to Nitrofurantoin and exhibit higher rates of resistance among common uropathogens like E. coli.
Choosing an online, on-demand format for your pharmacology CME allows you to integrate learning into your existing schedule. Rather than losing a weekend to a live conference, you can tackle the 120-question bank and pharmacology lectures in small, manageable segments. This "micro-learning" approach has been shown to improve retention and reduce the cognitive load associated with intensive, multi-day training sessions.
Whether you are preparing for the NCCPA Blueprint content or simply keeping your prescriptive authority active, the Pharmacology CME Review Package provides the necessary tools without the added stress of travel or rigid schedules.
Earning your AAPA Category 1 pharmacology credit does not have to be a source of burnout. By choosing a high-yield, self-assessment course, you can leverage the NCCPA multiplier, satisfy state requirements, and maximize your professional development budget with educational gift cards. Focus on efficiency so you can focus on your patients.
Explore our full range of courses, including the PANRE Review Course and specialized tracks in Internal Medicine, to stay current and compliant in your practice.
Course price: $399.99Access: 30 monthsIncluded practice: 2,500+ board-style questions and five 240-question practice examsCME: Up…
Price: $399.99Access: 30 monthsIncluded: 2,500+ PANRE practice questions, five full-length practice exams, and up to…
PANRE Review Course: Know What You Are Buying Price: $399.99Access: 30 monthsCME: Up to 100…
Stop treating exam prep and CME logging as separate chores. The PANRE Review Course's 100…
Course price: $399.99Access: 30 monthsCME: Up to 100 hours of AAPA Category 1 CME from…
Price: $399.99Access: 30 monthsIncluded practice: 2,500+ board-style questionsFull-length exams: Five 240-question practice examsCME: Up to…